Correction to: Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn's Disease: An Integrated Analysis of Phase II/III Clinical Development Programs

Drug Saf. 2019 Jun;42(6):809. doi: 10.1007/s40264-019-00816-3.

¹ Institute of Translational Medicine and NIHR Birmingham Biomedical Research Centre, University of Birmingham, Office 04, Ground Floor, ITM, North Block, Heritage Building, Mindelson Way, Edgbaston, Birmingham, B15 2TH, UK. [email protected].
² Axial Spondyloarthritis Clinic, University of California San Francisco, 400 Parnassus Ave., Floor B1, San Francisco, CA, 94143, USA.
³ Janssen Research & Development, LLC, 1400 McKean Road, Spring House, PA, 19477, USA.
⁴ Janssen Scientific Affairs, LLC, 800 Ridgeview Drive, Horsham, PA, 19044, USA.
⁵ Drexel University College of Medicine, 219 N. Broad Street, Floor 9, Philadelphia, PA, 19107, USA.
⁶ Department of Dermatology, University of Connecticut Health Center, 21 South Road, 2nd Floor, Farmington, CT, 06030, USA.
⁷ Probity Medical Research, 135 Union Street E, Waterloo, ON, N2J 1C4, Canada.

Abstract

In the original publication of this article, the following correction should be noted in Table 5.